<p>In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain. </p> <p>www.psychedelicstoday.com</p>

PT351 – Seth Rosenberg – The Trauma In Being Arrested and The Injustice of the Drug War

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.